Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course

M. K. Racke, D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, D. E. Scott

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by central nervous system inflammation and demyelination. Retinoids regulate cell differentiation and growth by binding to and activating retinoic acid receptors, which seem to be nuclear transcription factors. The effect of retinoids on chronic relapsing EAE produced by the transfer of myelin basic protein (MBP)-specific lymph node cells (LNC) was studied. All-trans-retinoic acid (tRA) inhibited the proliferation of MBP- specific LNC in vitro. However, the capacity of these cells to transfer EAE was markedly reduced by concentrations of tRA that only mildly inhibited T cell proliferation. The presence of tRA during in vitro MBP-specific LNC activation resulted in a considerable increase in IL-4 mRNA, whereas mRNA for IL-2, TNF-α, and IFN-γ was decreased. Increased IL-4 also was detected in culture supernatants. However, the presence of a neutralizing Ab to IL-4 (11B11) during MBP-specific LNC activation in vitro did not reverse the inhibition of encephalitogenicity caused by tRA. The administration of retinoids in vivo resulted in an improved clinical course, even when given after disease onset. These findings suggest that T cell activation in the presence of tRA results in the development of T cells of the Th2 phenotype, which, in turn, might be responsible for the decrease in the encephalitogenicity of MBP-specific T cells. The modulation by retinoids of an immune response dominated by Th1-like T cells to one in which the protective cytokines of Th2-like cells predominate may have potential relevance for human demyelinating diseases such as multiple sclerosis.

Original languageEnglish (US)
Pages (from-to)450-458
Number of pages9
JournalJournal of Immunology
Volume154
Issue number1
StatePublished - 1995
Externally publishedYes

Fingerprint

Myelin Basic Protein
Autoimmune Experimental Encephalomyelitis
Retinoids
Tretinoin
Interleukin-4
T-Lymphocytes
Lymph Nodes
Demyelinating Diseases
Th2 Cells
Messenger RNA
Retinoic Acid Receptors
Autoimmune Diseases
Multiple Sclerosis
Interleukin-2
Cell Differentiation
Transcription Factors
Central Nervous System
Cell Proliferation
Cytokines
Inflammation

ASJC Scopus subject areas

  • Immunology

Cite this

Racke, M. K., Burnett, D., Pak, S. H., Albert, P. S., Cannella, B., Raine, C. S., ... Scott, D. E. (1995). Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. Journal of Immunology, 154(1), 450-458.

Retinoid treatment of experimental allergic encephalomyelitis : IL-4 production correlates with improved disease course. / Racke, M. K.; Burnett, D.; Pak, S. H.; Albert, P. S.; Cannella, B.; Raine, C. S.; McFarlin, D. E.; Scott, D. E.

In: Journal of Immunology, Vol. 154, No. 1, 1995, p. 450-458.

Research output: Contribution to journalArticle

Racke, MK, Burnett, D, Pak, SH, Albert, PS, Cannella, B, Raine, CS, McFarlin, DE & Scott, DE 1995, 'Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course', Journal of Immunology, vol. 154, no. 1, pp. 450-458.
Racke, M. K. ; Burnett, D. ; Pak, S. H. ; Albert, P. S. ; Cannella, B. ; Raine, C. S. ; McFarlin, D. E. ; Scott, D. E. / Retinoid treatment of experimental allergic encephalomyelitis : IL-4 production correlates with improved disease course. In: Journal of Immunology. 1995 ; Vol. 154, No. 1. pp. 450-458.
@article{9ec1623ab5564a61b44013f5fd2d6565,
title = "Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course",
abstract = "Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by central nervous system inflammation and demyelination. Retinoids regulate cell differentiation and growth by binding to and activating retinoic acid receptors, which seem to be nuclear transcription factors. The effect of retinoids on chronic relapsing EAE produced by the transfer of myelin basic protein (MBP)-specific lymph node cells (LNC) was studied. All-trans-retinoic acid (tRA) inhibited the proliferation of MBP- specific LNC in vitro. However, the capacity of these cells to transfer EAE was markedly reduced by concentrations of tRA that only mildly inhibited T cell proliferation. The presence of tRA during in vitro MBP-specific LNC activation resulted in a considerable increase in IL-4 mRNA, whereas mRNA for IL-2, TNF-α, and IFN-γ was decreased. Increased IL-4 also was detected in culture supernatants. However, the presence of a neutralizing Ab to IL-4 (11B11) during MBP-specific LNC activation in vitro did not reverse the inhibition of encephalitogenicity caused by tRA. The administration of retinoids in vivo resulted in an improved clinical course, even when given after disease onset. These findings suggest that T cell activation in the presence of tRA results in the development of T cells of the Th2 phenotype, which, in turn, might be responsible for the decrease in the encephalitogenicity of MBP-specific T cells. The modulation by retinoids of an immune response dominated by Th1-like T cells to one in which the protective cytokines of Th2-like cells predominate may have potential relevance for human demyelinating diseases such as multiple sclerosis.",
author = "Racke, {M. K.} and D. Burnett and Pak, {S. H.} and Albert, {P. S.} and B. Cannella and Raine, {C. S.} and McFarlin, {D. E.} and Scott, {D. E.}",
year = "1995",
language = "English (US)",
volume = "154",
pages = "450--458",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Retinoid treatment of experimental allergic encephalomyelitis

T2 - IL-4 production correlates with improved disease course

AU - Racke, M. K.

AU - Burnett, D.

AU - Pak, S. H.

AU - Albert, P. S.

AU - Cannella, B.

AU - Raine, C. S.

AU - McFarlin, D. E.

AU - Scott, D. E.

PY - 1995

Y1 - 1995

N2 - Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by central nervous system inflammation and demyelination. Retinoids regulate cell differentiation and growth by binding to and activating retinoic acid receptors, which seem to be nuclear transcription factors. The effect of retinoids on chronic relapsing EAE produced by the transfer of myelin basic protein (MBP)-specific lymph node cells (LNC) was studied. All-trans-retinoic acid (tRA) inhibited the proliferation of MBP- specific LNC in vitro. However, the capacity of these cells to transfer EAE was markedly reduced by concentrations of tRA that only mildly inhibited T cell proliferation. The presence of tRA during in vitro MBP-specific LNC activation resulted in a considerable increase in IL-4 mRNA, whereas mRNA for IL-2, TNF-α, and IFN-γ was decreased. Increased IL-4 also was detected in culture supernatants. However, the presence of a neutralizing Ab to IL-4 (11B11) during MBP-specific LNC activation in vitro did not reverse the inhibition of encephalitogenicity caused by tRA. The administration of retinoids in vivo resulted in an improved clinical course, even when given after disease onset. These findings suggest that T cell activation in the presence of tRA results in the development of T cells of the Th2 phenotype, which, in turn, might be responsible for the decrease in the encephalitogenicity of MBP-specific T cells. The modulation by retinoids of an immune response dominated by Th1-like T cells to one in which the protective cytokines of Th2-like cells predominate may have potential relevance for human demyelinating diseases such as multiple sclerosis.

AB - Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by central nervous system inflammation and demyelination. Retinoids regulate cell differentiation and growth by binding to and activating retinoic acid receptors, which seem to be nuclear transcription factors. The effect of retinoids on chronic relapsing EAE produced by the transfer of myelin basic protein (MBP)-specific lymph node cells (LNC) was studied. All-trans-retinoic acid (tRA) inhibited the proliferation of MBP- specific LNC in vitro. However, the capacity of these cells to transfer EAE was markedly reduced by concentrations of tRA that only mildly inhibited T cell proliferation. The presence of tRA during in vitro MBP-specific LNC activation resulted in a considerable increase in IL-4 mRNA, whereas mRNA for IL-2, TNF-α, and IFN-γ was decreased. Increased IL-4 also was detected in culture supernatants. However, the presence of a neutralizing Ab to IL-4 (11B11) during MBP-specific LNC activation in vitro did not reverse the inhibition of encephalitogenicity caused by tRA. The administration of retinoids in vivo resulted in an improved clinical course, even when given after disease onset. These findings suggest that T cell activation in the presence of tRA results in the development of T cells of the Th2 phenotype, which, in turn, might be responsible for the decrease in the encephalitogenicity of MBP-specific T cells. The modulation by retinoids of an immune response dominated by Th1-like T cells to one in which the protective cytokines of Th2-like cells predominate may have potential relevance for human demyelinating diseases such as multiple sclerosis.

UR - http://www.scopus.com/inward/record.url?scp=0028876611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028876611&partnerID=8YFLogxK

M3 - Article

C2 - 7527821

AN - SCOPUS:0028876611

VL - 154

SP - 450

EP - 458

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -